Pantheris First-Ever Image-Guided Atherectomy Device Designed to Empower Physicians to Precisely Remove Plaque While Avoiding Disruption of Healthy Arteries
Deborah is the first hospital in New Jersey to offer a new treatment recently cleared by the U.S. Food and Drug Administration (FDA) to provide relief for patients suffering from the painful symptoms of peripheral artery disease, or PAD – a condition caused by a build-up of plaque that blocks blood flow in the arteries of legs or feet.
The device, Avinger’s Pantheris™ lumivascular atherectomy system, is an innovative image-guided therapy that, for the first time ever, allows physicians to see and remove plaque simultaneously during atherectomy – a minimally invasive procedure that involves cutting plaque away from the artery and clearing it out to restore blood flow.
Because the Pantheris device incorporates real-time optical coherence tomography (OCT) imaging on a therapeutic catheter – like having a small camera on the tip of the device – physicians are able to remove this plaque more precisely than ever before, with less risk of damage to the artery walls which can result in aggressive scarring that greatly increases the risk of restenosis, or re-narrowing of the artery. In the past, physicians have had to rely solely on X-ray as well as touch and feel to guide their tools while they try to treat complicated arterial disease.
For patients, this safe and more-precise treatment may potentially reduce the need for follow-up procedures and stents.
“We are excited to be able to use this new technology,” said Vincent Varghese, DO, Attending, Cardiac Interventionalist. “This is a major step forward in treating PAD. Previously we only had x-rays and our sense of touch. Now we can actually see the plaque, and more precisely remove it, safer and with less risk of damaging the vessel.”